Literature DB >> 8666141

MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.

D V Serreze1, W S Gallichan, D P Snider, K Croitoru, K L Rosenthal, E H Leiter, G J Christianson, M E Dudley, D C Roopenian.   

Abstract

The common class I alleles (e.g., Kd and Db) within the H2g7 major histocompatibility complex (MHC) clearly contribute to autoimmune IDDM in NOD mice, but the mechanism by which this occurs has been controversial. One laboratory has reported that the peptide transporter encoded by the Tap1 gene within H2g7 is defective, and this contributes to IDDM by impairing MHC class I-mediated antigen presentation. If true, defective MHC class I-mediated antigen presentation should segregate with the H2g7 haplotype. NOD mice, related congenic stocks, and other control strains were used to test this hypothesis. H2g7-positive strains did not differ from those expressing other MHC haplotypes in ability to present MHC class I-restricted H3aa or H3ab minor histocompatibility (H) antigens to cytotoxic T-lymphocytes (CTL). The H2g7 haplotype was found to have a reduced capacity to mediate MHC class I-restricted presentation of the H47a minor H antigen. However, MHC class I-restricted presentation of H47a was found to be Tap independent. NOD mice and control strains also did not differ in ability to activate adenovirus-specific MHC class I restricted CTL. Thus, the H2g7 haplotype is not characterized by a Tap gene defect that only impairs the inductive phase of the immune response. In addition, MHC class I-restricted presentation of either minor H or adenoviral antigens was equivalent in male and female NOD mice. Therefore, while the class I alleles of the H2g7 haplotype exert diabetogenic functions in NOD mice, this is not elicited through a Tap gene defect. The absence of female-specific Tap gene defects also indicates this cannot account for the reduced male incidence of IDDM in some NOD mouse colonies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666141     DOI: 10.2337/diab.45.7.902

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis.

Authors:  Manjunatha Ankathatti Munegowda; Yulin Deng; Rajni Chibbar; Qingyong Xu; Andrew Freywald; Sean J Mulligan; Sylvia van Drunen Littel-van den Hurk; Deming Sun; Sidong Xiong; Jim Xiang
Journal:  J Clin Immunol       Date:  2011-06-15       Impact factor: 8.317

Review 3.  Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.

Authors:  Jonathan D Katz; Edith M Janssen
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

4.  Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells.

Authors:  Gregory Berry; Hanspeter Waldner
Journal:  J Vis Exp       Date:  2013-05-06       Impact factor: 1.355

5.  Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice.

Authors:  Michele P Marron; Robert T Graser; Harold D Chapman; David V Serreze
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-02       Impact factor: 11.205

6.  Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement.

Authors:  T P DiLorenzo; R T Graser; T Ono; G J Christianson; H D Chapman; D C Roopenian; S G Nathenson; D V Serreze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

7.  FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Katalin Olasz; Akos Hegyi; Katalin Mikecz; Tibor T Glant; Tibor A Rauch
Journal:  Cardiovasc Pathol       Date:  2016-05-17       Impact factor: 2.185

8.  Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations.

Authors:  Jenny M Phillips; Nicole M Parish; Tim Raine; Chris Bland; Yvonne Sawyer; Hugo De La Peña; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2009-08-10

9.  Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.

Authors:  C E Mathews; R T Graser; A Savinov; D V Serreze; E H Leiter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.

Authors:  Helen M McGuire; Stacey Walters; Alexis Vogelzang; Carol M Y Lee; Kylie E Webster; Jonathan Sprent; Daniel Christ; Shane Grey; Cecile King
Journal:  Diabetes       Date:  2011-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.